We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Higher Death Rate Seen With Medtronic Stent System
FDA: Higher Death Rate Seen With Medtronic Stent System
March 21, 2008
The FDA has issued a public health notice advising doctors to continue monitoring patients who have received Medtronic’s AneuRx stent graft system to treat abdominal aortic aneurysm ruptures.